dementia

— Research offers insight into the possibility of predicting Alzheimer's risk decades ahead PHILADELPHIA — Specific blood biomarkers associated with Alzheimer’s disease — particularly amyloid-beta 42/40 ratios and measures of phosphorylated tau 181 (p-tau181) — were found to be linked to later-life dementia, a retrospective study has revealed. These midlife biomarkers demonstrated a long-lasting association with amyloid positivity and eventual dementia, according to findings shared by

— Update from Lancet Commission incorporates vision loss, high LDL to risk factors PHILADELPHIA -- The Lancet Commission on dementia prevention, intervention, and care has expanded the list of modifiable risk factors linked to cognitive decline to 14, after new research conducted since its previous report in 2020. Vision loss and elevated low-density lipoprotein (LDL) cholesterol have been added to the commission's risk factor list, which previously included 12. This revised 57-page

— Replacing weekly servings of bacon or hot dogs with nuts and legumes linked to reduced dementia risk PHILADELPHIA – A long-term observational study involving 130,000 healthcare professionals found that eating processed red meat twice a week over several decades was associated with a higher likelihood of developing dementia. Participants from the Nurses' Health Study and the Health Professionals Follow-Up Study who consumed at least one-quarter of a daily serving of processed red meat —

— Recombinant Shingles Vaccine Linked to 164 Days Free from Dementia Diagnosis Key Points Those who received the recombinant shingles vaccine (Shingrix) saw a 17% longer duration without a dementia diagnosis compared to patients who got the live vaccine version. This extension translates to 164 more days on average without receiving a dementia diagnosis. The findings add to the growing understanding of a potential link between shingles vaccination and the prevention of dementia. A recent

— Age-Related Outcomes A retrospective analysis involving Medicare patients suggested that hormone therapy in older women with breast cancer was linked to a lower risk of developing dementia. The study showed that breast cancer patients who underwent hormone-modulating therapy had a 7% reduced likelihood of dementia over an average follow-up of 12 years compared with those who didn’t receive the therapy (HR 0.93, 95% CI 0.88-0.98, P=0.005), according to research led by Chao Cai, PhD, from the